Elos Medtech Balance Sheet Health
Financial Health criteria checks 6/6
Elos Medtech has a total shareholder equity of SEK788.2M and total debt of SEK407.1M, which brings its debt-to-equity ratio to 51.6%. Its total assets and total liabilities are SEK1.6B and SEK772.0M respectively. Elos Medtech's EBIT is SEK136.9M making its interest coverage ratio 3.2. It has cash and short-term investments of SEK117.3M.
Key information
51.6%
Debt to equity ratio
kr407.10m
Debt
| Interest coverage ratio | 3.2x |
| Cash | kr117.30m |
| Equity | kr788.20m |
| Total liabilities | kr772.00m |
| Total assets | kr1.56b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ELOS BTA B's short term assets (SEK577.9M) exceed its short term liabilities (SEK289.8M).
Long Term Liabilities: ELOS BTA B's short term assets (SEK577.9M) exceed its long term liabilities (SEK482.2M).
Debt to Equity History and Analysis
Debt Level: ELOS BTA B's net debt to equity ratio (36.8%) is considered satisfactory.
Reducing Debt: ELOS BTA B's debt to equity ratio has reduced from 57.1% to 51.6% over the past 5 years.
Debt Coverage: ELOS BTA B's debt is well covered by operating cash flow (23.4%).
Interest Coverage: ELOS BTA B's interest payments on its debt are well covered by EBIT (3.2x coverage).